Prostate Adenocarcinoma Grade Group 1: Rationale for Retaining a Cancer Label in the 2022 World Health Organization

George J Netto1, Mahul B Amin2, Eva M Compérat3

  • 1Department of Pathology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.

European Urology
|October 6, 2022
PubMed